2 min read
FDA Prior Knowledge Guidance: A New Framework for Natural History Evidence
June 22, 2026
What the FDA's prior knowledge guidance means for natural history evidence and shared datasets
On June 2,...
Meet Veristat in Barcelona at BIO-Europe Spring 2024, 18-20 March 2024
With nearly 30 years of experience in clinical trial planning and execution, Veristat is equipped to support any development program.
If you are transitioning your compound into clinical trials, you need the right partner to guide your planning and decision-making. Whether you are preparing your IND/CTA, or you are looking to recruit patients quickly to get your early phase trials running, or just need medical writing or biostatistical support for your programs – Veristat can help.
As a flexible CRO and consultancy, we provide impactful solutions on a full-service or functional service basis, integrating strategic planning, regulatory expertise, and clinical trial execution to rapidly advance the most complex or novel therapies.
Don't miss this opportunity to connect with us and learn more about how Veristat is making a difference in the lives of patients with rare and ultra-rare diseases.
Where Data Becomes Direction for complex clinical programs
Schedule A Meeting
Veristat team member, Balma Gil, Senior Business Development Director, will be at the venue, ready to listen to your needs and share Veristat’s expertise.
You can arrange a meeting by completing the form on the right side of this page. Discover how we can assist you in progressing your upcoming clinical trial or regulatory submission towards a successful outcome or explore our wide range of capabilities.
Conference Details
Website: BIO EUROPE SPRING 2024
Schedule A Meeting
Meet with us at BIO EUROPE SPRING 2024 by filling out the form below.
Event Topics:
5 min read
ASCO 2026: ADCs Are Redefining What Targeted Therapy Can Do
Jul 2, 2026 Veristat Blog
Antibody-drug conjugates — or ADCs — are not new. The concept of a "magic bullet" that delivers a cytotoxic payload...